Cytrellis Biosystems Completes $28.5 Million Series B Financing
Supports company's clinical, product development and regulatory efforts Michael Peterson, CTO Merz Device Innovation Center, joins Board of Directors WOBURN, Mass., June 5, 2018 -- (Healthcare Sales & Marketing Network) -- Cytrellis Biosystems, Inc.... Devices, Dermatology, Venture Capital, Personnel Cytrellis Biosystems (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 5, 2018 Category: Pharmaceuticals Source Type: news

IDEAYA Biosciences Appoints Paul Stone, J.D., as Senior Vice President and General Counsel, Head of Operations and Mark Lackner, Ph.D. as Vice President, Head of Biomarkers and Synthetic Lethal Biology
SOUTH SAN FRANCISCO, Calif., Jun. 5, 2018 -- (Healthcare Sales & Marketing Network) -- IDEAYA Biosciences, Inc., an oncology-focused biotechnology company committed to the discovery of breakthrough synthetic lethality medicines and immuno-oncology therapi... Biopharmaceuticals, Oncology, Personnel IDEAYA Biosciences, immunotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 5, 2018 Category: Pharmaceuticals Source Type: news

Philips receives U.S. FDA 510(k) clearance for its Ingenia Elition MR solution
With first U.S. commercial installation at Hennepin Healthcare, the Philips Ingenia Elition performs MRI exam times up to 50% [1] faster with no compromise in image quality AMSTERDAM, June 5, 2018 -- (Healthcare Sales & Marketing Network) -- Royal Phil... Devices, Radiology, FDA Royal Philips, Ingenia Elition, magnetic resonance imaging (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 5, 2018 Category: Pharmaceuticals Source Type: news

Volpara Solutions Launches Enhanced Volpara(R)Positioning(TM) Software Featuring New Approach to Standardizing Mammographic Image Evaluation
Developed Based on Data from more than 1 Million Studies, VolparaPositioning Software is Designed to Help Breast Imaging Facilities Achieve and Maintain High-Quality Screening WELLINGTON, New Zealand, June 5, 2018 -- (Healthcare Sales & Marketing Networ... Devices, Radiology, Product Launch Volpara Solutions, VolparaPositioning, VolparaEnterprise, breast imaging (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 5, 2018 Category: Pharmaceuticals Source Type: news

Audentes Announces Priority Medicines (PRIME) Designation Granted by the European Medicines Agency to AT132 for the treatment of X-Linked Myotubular Myopathy
SAN FRANCISCO, June 5, 2018 -- (Healthcare Sales & Marketing Network) -- Audentes Therapeutics, Inc. (Nasdaq: BOLD), a biotechnology company focused on developing and commercializing innovative gene therapy products for patients living with serious, life-... Biopharmaceuticals, Regulatory Audentes Therapeutics, gene therapy, Myotubular Myopathy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 5, 2018 Category: Pharmaceuticals Source Type: news

Halyard Health Announces Agreement to Acquire CoolSystems, Inc., Marketed as Game Ready(R)
Game Ready's pain management and rehabilitation therapies enhance and diversify Halyard's non-opioid Pain Management portfolio Transaction expands Halyard's call point footprint, increasing access within the orthopedic and sports medicine markets and cr... Devices, Orthopaedic, Mergers & Acquisitions Halyard Health, CoolSystems, Game Ready, cold therapy, compression therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 5, 2018 Category: Pharmaceuticals Source Type: news

FDA Expands Lilly's ALIMTA(R) (pemetrexed) Label to Include Combination with KEYTRUDA(R) (pembrolizumab) and Carboplatin as First-Line Treatment for Metastatic Nonsquamous Non-Small Cell Lung Cancer, Irrespective of PD-L1 Expression
New approval based on KEYNOTE-021, Cohort G1, results INDIANAPOLIS, June 5, 2018 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has granted approval for a ... Biopharmaceuticals, Oncology, FDA Eli Lilly, ALIMTA, pemetrexed, KEYTRUDA, NSCLC (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 5, 2018 Category: Pharmaceuticals Source Type: news

Peer-Reviewed Study Demonstrates High Patient Satisfaction with Propeller Health's Digital Medicines for Asthma
Company's 15th peer-reviewed study adds valuable insights into how patients experience and perceive digital health interventions for asthma MADISON, Wis., June 5, 2018 -- (Healthcare Sales & Marketing Network) -- A new peer-reviewed study published in ... Devices Propeller Health, digital therapeutics, digital medicines, Asthma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 5, 2018 Category: Pharmaceuticals Source Type: news

AOBiome Therapeutics Announces Election of Dr. Jun Wang as Chairman of the Board of Directors
AOBiome Advancing Six Programs in Clinical Testing Based on Ammonia Oxidizing Bacteria (AOB) Platform Expertise CAMBRIDGE, Mass., June 4, 2018 -- (Healthcare Sales & Marketing Network) -- AOBiome Therapeutics ("AOBiome"), a world-leading clin... Biopharmaceuticals, Personnel AOBiome Therapeutics, Ammonia Oxidizing Bacteria (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 4, 2018 Category: Pharmaceuticals Source Type: news

Camber Spine Announces 510(k) Approval Of ENZA(TM)-A Titanium ALIF
WAYNE, Pa., June 4, 2018 -- (Healthcare Sales & Marketing Network) -- Camber Spine today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its ENZA™-A Titanium Anterior Lumbar Interbody Fusion (ALIF... Devices, Orthopaedic, Neurosurgery, FDA Camber Spine, ENZA-A, Titanium ALIF, Lumbar Interbody Fusion (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 4, 2018 Category: Pharmaceuticals Source Type: news

Blueprint Medicines and CStone Pharmaceuticals Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Avapritinib, BLU-554 and BLU-667 in Greater China
Combines Blueprint Medicines' Lead Clinical Programs with CStone Pharmaceutical's Regional Expertise Expands BLU-554 Development Program in Hepatocellular Carcinoma with Plans to Bring Ongoing Monotherapy Trial to China and Initiate Proof-of-Concept Com... Biopharmaceuticals, Oncology, Licensing Blueprint Medicines, CStone Pharmaceuticals, Avapritinib (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 4, 2018 Category: Pharmaceuticals Source Type: news

Codiak BioSciences Names Richard Brudnick Chief Business Officer and Head of Strategy
CAMBRIDGE, Mass., June 4, 2018 -- (Healthcare Sales & Marketing Network) -- Codiak BioSciences, Inc., the leading exosome therapeutics company, today announced the appointment of Richard Brudnick as Chief Business Officer and Head of Strategy. Mr. Brudnic... Biopharmaceuticals, Personnel Codiak BioSciences, exosome therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 4, 2018 Category: Pharmaceuticals Source Type: news

RDD Pharma Appoints Dr. Mark Sirgo as Board Chairman
NEW YORK, June 4, 2018 -- (Healthcare Sales & Marketing Network) -- RDD Pharma, a specialty pharma company focused on innovative therapies for anorectal diseases and gastrointestinal disorders, today announced the appointment of Dr. Mark Sirgo as the Chai... Biopharmaceuticals, Gatroenterology, Personnel RDD Pharma, anal fissure, fecal incontinence, colitis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 4, 2018 Category: Pharmaceuticals Source Type: news

Sosei Announces Appointment of Chris Cargill as Interim CFO
TOKYO and LONDON, June 4, 2018 -- (Healthcare Sales & Marketing Network) -- Sosei Group Corporation ("Sosei" or the "Company"; TSE Mothers Index: 4565), the world leader in GPCR medicine design and development, today announces that Mr.... Biopharmaceuticals, Personnel Sosei Corp, GPCR-targeted StaR, GPCR medicine design (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 4, 2018 Category: Pharmaceuticals Source Type: news

PENTAX Medical Introduces Next-Generation C2 CryoBalloon(TM) Ablation System for Treatment of Barrett's Esophagus
Endoscopic Device Uses Extreme Cold to Eradicate Precancerous Lesions and Minimize Post-Procedural Pain in 30-Minute Procedure MONTVALE, N.J., June 1, 2018 -- (Healthcare Sales & Marketing Network) -- PENTAX Medical Company, a healthcare industry leade... Devices, Gastroenterology, Product Launch PENTAX Medical, CryoBalloon, Ablation, Barrett's esophagus, GERD (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 1, 2018 Category: Pharmaceuticals Source Type: news

Halyard Health Announces Corporate Rebranding, Changes Name to Avanos Medical, Inc.
New name and brand underscore a difference in our products, people and processes to deliver game changing innovation in everything we do ALPHARETTA, Ga., June 1, 2018 -- (Healthcare Sales & Marketing Network) -- Halyard Health, Inc. (NYSE: HYH) a mark... Devices Halyard Health, Avanos Medical (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 1, 2018 Category: Pharmaceuticals Source Type: news

Amorsa Therapeutics Appoints Jeffrey Wiesen to Board of Directors
SOUTHBOROUGH, Mass., June 1, 2018 -- (Healthcare Sales & Marketing Network) -- Amorsa Therapeutics Inc., a neuropharmaceutical company pioneering the development of breakthrough treatments for nervous system disorders, is pleased to announce the appointme... Biopharmaceuticals, Neurology, Personnel Amorsa Therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 1, 2018 Category: Pharmaceuticals Source Type: news

BD Names John DeFord Chief Technology Officer
FRANKLIN LAKES, N.J., June 1, 2018 -- (Healthcare Sales & Marketing Network) -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today appointed John A. DeFord as executive vice president and chief technology of... Diagnostics, Devices, Personnel BD (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 1, 2018 Category: Pharmaceuticals Source Type: news

Lannett Receives FDA Approval For Levofloxacin Oral Solution; Imminent Launch Anticipated
PHILADELPHIA, June 1, 2018 -- (Healthcare Sales & Marketing Network) -- Lannett Company, Inc. (NYSE: LCI) today announced that it received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Levoflo... Biopharmaceuticals, Generics, FDA, Product Launch Lannett Company, Janssen Pharmaceuticals, Levofloxacin, Levaquin (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 1, 2018 Category: Pharmaceuticals Source Type: news

Fortuna Fix Announces Appointment of Madhavan Balachandran to Board of Directors
Jan-Eric Ahlfors, CEO of Fortuna Fix Inc., to present at IABS/CIRM 4th Cell Therapy Conference on June 6, 2018 in Los Angeles LONDON and MONTREAL, June 1, 2018 -- (Healthcare Sales & Marketing Network) -- Focusing on its Manufacturing, Fortuna Fix (&qu... Regenerative Medicine, Personnel Fortuna Fix, Spinal Cord Injury, Parkinson's Disease, Traumatic Brain Injury (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 1, 2018 Category: Pharmaceuticals Source Type: news

PENTAX Medical Announces U.S. Deal To Distribute Third Eye(R) Panoramic(TM) Imaging System For Colon Cancer Screening
Provides 'Panoramic' View to Detect Potentially Cancerous Polyps Standard Colonoscopes May Not See MONTVALE, N.J., May 31, 2018 -- (Healthcare Sales & Marketing Network) -- PENTAX Medical Company, a healthcare industry leader in diagnostic and therapeu... Devices, Gastroenterology, Oncology, Distribution PENTAX Medical, Avantis Medical Systems, Third Eye, colonoscopy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 31, 2018 Category: Pharmaceuticals Source Type: news

TELA Bio(R) Announces Plans to Launch OviTex(R) Reinforced BioScaffolds in Europe
Distinct class of surgical implants for hernia procedures to launch in Europe MALVERN, Pa., May 31, 2018 -- (Healthcare Sales & Marketing Network) -- TELA Bio®, Inc., a surgical reconstruction company leading the development and commercialization o... Devices, Surgery, Product Launch TELA Bio, OviTex, Reinforced BioScaffold, hernia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 31, 2018 Category: Pharmaceuticals Source Type: news

Curis Announces FDA Fast Track Designation for Fimepinostat Development in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
LEXINGTON, Mass., May 31, 2018 -- (Healthcare Sales & Marketing Network) -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development and commercialization of innovative therapeutics for the treatment of cancer, announced today that t... Biopharmaceuticals, Oncology, FDA Curis, fimepinostat, lymphoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 31, 2018 Category: Pharmaceuticals Source Type: news

Cingulate Therapeutics Strengthens Leadership with Two New Board Appointments
KANSAS CITY, Kan., May 31, 2018 -- (Healthcare Sales & Marketing Network) -- Cingulate Therapeutics LLC, a clinical stage biopharmaceutical company focused on the development of new and innovative products utilizing its precision timed release drug delive... Biopharmaceuticals, Drug Delivery, Personnel Cingulate Therapeutics, Dexmethylphenidate, Dextroamphetamine, ADHD (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 31, 2018 Category: Pharmaceuticals Source Type: news

Abbott Introduces the Afinion(TM) 2 Analyzer Rapid Test System for Diabetes Management
STATE-OF-THE-ART MULTI-ASSAY TEST SYSTEM HELPS PEOPLE WITH DIABETES GET THE HbA1c RESULTS THEY NEED WITHIN 3 MINUTES -- ALLOWING MORE TIME FOR CONSULTATION AND CARE DURING A SINGLE HEALTHCARE VISIT ABBOTT PARK, Ill., May 31, 2018 -- (Healthcare Sales & ... Diagnostics, Endocrinology, Product Launch Abbott, Afinion 2, HbA1c, diabetes (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 31, 2018 Category: Pharmaceuticals Source Type: news